COMP <GO>
VVV vs CBT // EV/EBITDA & P/E VALUATION
Valvoline Inc. (NYSE) VS. Cabot Corporation (NYSE) • 15-METRIC TALLY: VVV 6
— CBT 6
▲ EV/EBITDA & P/E VALUATION LEADER: CBT
LAST: $32.38 (+1.92%) • MKT CAP: $4.13B
valuation
9.3x
LAST: $73.85 (+0.11%) • MKT CAP: $3.81B
valuation
5.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VVV VS. CBT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VVV | CBT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.50% | 25.30% | +13.20 | VVV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.50% | 22.30% | -5.80 | CBT | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 9.3x | 5.2x | +4.10 | CBT | /valuation <GO> |
| Free Cash Flow Yield | 0.92% | 10.25% | -9.33 | CBT | /fcf-yield <GO> |
| Operating Margin | 22.80% | 16.70% | +6.10 | VVV | /operating-margins <GO> |
| Net Profit Margin | 12.30% | 8.90% | +3.40 | VVV | /net-margins <GO> |
| Revenue Growth (YoY) | 5.60% | -7.00% | +12.60 | VVV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.52% | -2.52 | CBT | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.46 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | CBT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.6 | 43.4 | +16.24 | VVV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.2x | 10.7x | +7.50 | CBT | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.13B | $3.81B | $318.3M | VVV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VVV REV | CBT REV | VVV GROSS % | CBT GROSS % | VVV FCF | CBT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.71B | $3.71B | 38.5% | 25.3% | $38.0M | $391.0M |
| FY 2024 | $1.62B | $3.99B | 38.2% | 24.0% | $40.7M | $451.0M |
| FY 2023 | $1.44B | $3.93B | — | — | -$105.8M | $595.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VVV // BETA 0.98
CBT // BETA —